InMed Pharmaceuticals Inc.
INM
$2.96
$0.24378.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M |
| Total Depreciation and Amortization | 129.10K | 145.00K | 151.90K | 150.70K | 152.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.90K | 33.70K | 91.00K | 56.70K | 187.20K |
| Change in Net Operating Assets | -94.10K | -327.60K | 665.60K | -418.80K | -709.80K |
| Cash from Operations | -2.50M | -1.83M | -1.03M | -1.93M | -1.85M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -9.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | -9.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 396.20K | 1.03M | 200.00 | 0.00 | 5.22M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -57.60K | -191.80K | -- | -- | -562.20K |
| Cash from Financing | 338.50K | 838.20K | 200.00 | 0.00 | 4.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.16M | -988.60K | -1.03M | -1.93M | 2.80M |